Japan said on Thursday it will procure a majority of 120 million doses of AstraZeneca Plc's COVID-19 vaccine from domestic makers, as production problems overseas have raised concerns over timely distribution.
Press release content from Business Wire. The AP news staff was not involved in its creation.
ENHERTU® Receives Prime Minister’s Award from the Japan Techno-Economics Society
January 27, 2021 GMT
Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that ENHERTU
® (trastuzumab deruxtecan), a HER2 directed antibody drug conjugate (ADC), received the Prime Minister’s Award at the 9 th Technology Management and Innovation Awards hosted by the Japan Techno-Economics Society (JATES).
The Technology Management and Innovation Awards were established in 2012 with the objective of contributing to the development of the nation’s economy, social changes, and the promotion of a global competitive edge by widely introducing technological innovations originating in Japan. This year marks the 9 th year of the award.
Rest of World News: TOKYO: AstraZeneca Plc has told Japan's health ministry it would produce more than 90 million coronavirus vaccine shots in the country, Japan's top go.
AstraZeneca Plc has told Japan’s health ministry it would produce more than 90 million coronavirus vaccine shots in the country, Japan’s top government spokesman said on Thursday.